RNA – avidity biosciences, inc. (US:NASDAQ)
Stock Stats
News
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Avidity Biosciences, Inc. (NASDAQ: RNA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $72.00 price target on the stock.
Avidity Biosciences to Participate in Upcoming Investor Conference
Avidity Biosciences, Inc. (NASDAQ: RNA) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $67.00 price target on the stock.
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Form 4 Avidity Biosciences, For: Dec 18 Filed by: Flanagan W. Michael
Form 4 Avidity Biosciences, For: Dec 18 Filed by: MacLean Michael F
Form 4 Avidity Biosciences, For: Dec 18 Filed by: Boyce Sarah
Form 4 Avidity Biosciences, For: Dec 18 Filed by: McCarthy Teresa
Form 4 Avidity Biosciences, For: Dec 16 Filed by: McCarthy Teresa
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.